Original Research
The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa

https://doi.org/10.1016/j.jcmgh.2019.10.007Get rights and content
Under a Creative Commons license
open access

Background & Aims

Gastric carcinoma is related mostly to CagA+-Helicobacter pylori infection, which disrupts the gastric mucosa turnover and elicits an epithelial-mesenchymal transition (EMT) and preneoplastic transdifferentiation. The tumor suppressor Hippo pathway controls stem cell homeostasis; its core, constituted by the large tumor suppressor 2 (LATS2) kinase and its substrate Yes-associated protein 1 (YAP1), was investigated in this context.

Methods

Hippo, EMT, and intestinal metaplasia marker expression were investigated by transcriptomic and immunostaining analyses in human gastric AGS and MKN74 and nongastric immortalized RPE1 and HMLE epithelial cell lines challenged by H pylori, and on gastric tissues of infected patients and mice. LATS2 and YAP1 were silenced using small interfering RNAs. A transcriptional enhanced associated domain (TEAD) reporter assay was used. Cell proliferation and invasion were evaluated.

Results

LATS2 and YAP1 appear co-overexpressed in the infected mucosa, especially in gastritis and intestinal metaplasia. H pylori via CagA stimulates LATS2 and YAP1 in a coordinated biphasic pattern, characterized by an early transient YAP1 nuclear accumulation and stimulated YAP1/TEAD transcription, followed by nuclear LATS2 up-regulation leading to YAP1 phosphorylation and targeting for degradation. LATS2 and YAP1 reciprocally positively regulate each other’s expression. Loss-of-function experiments showed that LATS2 restricts H pylori–induced EMT marker expression, invasion, and intestinal metaplasia, supporting a role of LATS2 in maintaining the epithelial phenotype of gastric cells and constraining H pylori–induced preneoplastic changes.

Conclusions

H pylori infection engages a number of signaling cascades that alienate mucosa homeostasis, including the Hippo LATS2/YAP1/TEAD pathway. In the host–pathogen conflict, which generates an inflammatory environment and perturbations of the epithelial turnover and differentiation, Hippo signaling appears as a protective pathway, limiting the loss of gastric epithelial cell identity that precedes gastric carcinoma development.

Keywords

YAP1
Epithelial-to-Mesenchymal Transition
Adenocarcinoma
CagA

Abbreviations used in this paper

BMP1
bone morphogenic protein-1
Ca-Mg
1 mmol/L CaCl2 and 1 mmol/L MgCl2
cagPAI
cytotoxin-associated gene A-Pathogenicity Island
CDX2
caudal-type homeobox protein 2
CTGF
conective tissue growth factor
EMT
epithelial-to-mesenchymal transition
GC
gastric adenocarcinoma
HMLE
human mammary epithelial cells
HPI
Helicobacter pylori infection
IAP
intestinal alkaline phosphatase
KRT7
keratin 7
LATS2
large tumor suppressor 2
MMP9
matrix metalloproteinase 9
mRNA
messenger RNA
MST1/2
Mammalian Ste20-like kinases 1/2
MUC2
mucin 2
NF-κB
nuclear factor-κB
RPE1
retinal pigment epithelial cells
RT-qPCR
reverse-transcription quantitative polymerase chain reaction
siControl
small interference RNA Control
TEAD
transcriptional enhanced associated domain
VGLL4
vestigial-like family member 4
WT
wild-type
ZEB1
Zinc finger E-box-binding homeobox 1

Cited by (0)

Author contributions Silvia Elena Molina Castro acquired, analyzed, and interpreted the data, performed the statistical analysis, and drafted the manuscript; Julie Giraud and Camille Tiffon acquired, analyzed, and interpreted the data, and performed the statistical analysis; Elodie Sifre and Alban Giese provided technical support; Geneviève Belleannée and Hélène Boeuf provided material support; Hélène Boeuf, Emilie Bessède, Philippe Lehours, Francis Mégraud, and Pierre Dubus critically revised the manuscript for important intellectual content; Cathy Staedel was responsible for the study concept, acquired, analyzed, and interpreted the data, and drafted the manuscript; and Christine Varon was responsible for the study concept, analyzed and interpreted the data, designed and supervised the study, drafted the manuscript, and obtained funding.

Conflicts of interest The authors disclose no conflicts.

Funding Supported by the French National Institute for Cancer (PLBio 2014-152 to J.G. and C.T.), and the French Association Ligue Nationale Contre le Cancer (C.T.). Silvia Elena Molina Castro is a PhD fellowship recipient of the University of Costa Rica (San José, Costa Rica) and the Ministry of Science, Technology and Communications (Costa Rica).